Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systemic therapy for metastatic malignant melanoma - from deeply disappointing to bright future?

Published:2008-05 Issue:5 Volume:17 Page:383-394
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:

Author:

Lorigan Paul,Eisen Tim,Hauschild Axel

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0625.2007.00673.x/fullpdf

Reference125 articles.

1. 1http://seer.cancer.gov/statfacts/.

2. Epidemiology of cutaneous melanoma in Germany and Worldwide;Garbe;Skin Pharmacol Physiol,2001

3. 3http://info.cancerresearchuk.org/cancerstats/types/melanoma/.

4. 4http://www.aihw.gov.au/dataonline.cfm.

5. 5http://www.health.qld.gov.au/hic/qcr2005/1982_03_text.pdf.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Targeting by β-Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization;Nutrition and Cancer;2019-08-07

2. Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation;Experimental Dermatology;2014-09

3. Catalytic and anticancer activities of sawhorse-type diruthenium tetracarbonyl complexes derived from fluorinated fatty acids;Journal of Coordination Chemistry;2013-05-01

4. In vivoefficacy of melanoma internal radionuclide therapy with a131I-labelled melanin-targeting heteroarylcarboxamide molecule;International Journal of Cancer;2013-03-18

5. A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation;Cancer Chemotherapy and Pharmacology;2013-02-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3